Ingalls & Snyder LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,354 shares of the company’s stock after selling 2,197 shares during the quarter. Ingalls & Snyder LLC’s holdings in Colgate-Palmolive were worth $10,516,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. OLD Second National Bank of Aurora purchased a new position in shares of Colgate-Palmolive in the second quarter valued at $109,000. Krilogy Financial LLC grew its holdings in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares in the last quarter. Harbour Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive in the first quarter valued at $121,000. Hanson & Doremus Investment Management grew its holdings in shares of Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after purchasing an additional 70 shares in the last quarter. Finally, Captrust Financial Advisors purchased a new position in shares of Colgate-Palmolive in the second quarter valued at $122,000. 72.96% of the stock is owned by institutional investors and hedge funds.

Shares of Colgate-Palmolive (CL) opened at $73.24 on Friday. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27. The firm has a market capitalization of $64,409.02, a price-to-earnings ratio of 25.56, a PEG ratio of 3.36 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period last year, the company earned $0.73 earnings per share. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. equities research analysts predict that Colgate-Palmolive will post 2.88 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were given a dividend of $0.40 per share. The ex-dividend date was Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.

CL has been the subject of a number of analyst reports. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Jefferies Group restated a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Morgan Stanley lowered their price target on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research report on Tuesday, October 31st. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Macquarie initiated coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 price target for the company. Two investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the company’s stock. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $76.04.

In other news, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CMO Mukul Deoras sold 7,500 shares of Colgate-Palmolive stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at $3,313,501.76. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 173,673 shares of company stock valued at $12,629,293. Corporate insiders own 1.02% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive (CL) Shares Sold by Ingalls & Snyder LLC” was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.watchlistnews.com/colgate-palmolive-cl-shares-sold-by-ingalls-snyder-llc/1765408.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.